Improved treatment for acute physical insult to the central nervous system
CA 2419845 A1 · Owner: University Of Saskatchewan · Inventors: Paterson, Phyllis G.; Griebel, Robert W.; Juurlink, Bernhard H. J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method of promoting functional recovery and reducing oxidative stress and inflammation following an acute physical insult to the central nervous system comprising administering to a mammalian patient which has suffered an acute physical insult to the central nervous system an initial dose of L-2oxothiazolidine-4-carboxylate ("OTC") or a variant thereof is disclosed. This method preferably further includes the step of administering a number of subsequent doses of OTC or a variant thereof at subsequent time periods. Also provided is a use of OTC or a variant thereof in the preparation of a medicament useful in reducing inflammation in the central nervous system and promoting the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 17, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 17, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 17, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.